First National Advisers LLC Sells 1,048 Shares of Humana Inc. (NYSE:HUM)

First National Advisers LLC reduced its position in Humana Inc. (NYSE:HUM) by 27.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 2,715 shares of the insurance provider’s stock after selling 1,048 shares during the quarter. First National Advisers LLC’s holdings in Humana were worth $689,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of HUM. FPC Investment Advisory Inc. bought a new position in shares of Humana in the 4th quarter worth $27,000. Centricity Wealth Management LLC bought a new position in Humana during the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA lifted its stake in Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new position in Humana during the 4th quarter valued at $33,000. Finally, Atwood & Palmer Inc. lifted its stake in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 60 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HUM has been the topic of several recent analyst reports. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Morgan Stanley dropped their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial raised their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Nineteen research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus price target of $285.68.

Humana Trading Up 0.5 %

Shares of HUM opened at $253.11 on Monday. The business has a 50-day moving average of $271.37 and a 200 day moving average of $279.50. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The firm has a market cap of $30.55 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is presently 35.58%.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.